创新型手术机器人研发商康诺思腾完成新一轮约2亿美元超募融资

Core Insights - Cornerstone Robotics, a Chinese innovative surgical robot developer, has completed a new funding round of approximately $200 million, attracting investments from various global and local investors [2][3] - The funding will primarily accelerate commercialization in China and overseas, as well as support the development and clinical registration of next-generation products [3] Company Overview - Founded in September 2019, Cornerstone Robotics has developed a full product chain including surgical robot systems, imaging systems, energy platforms, pneumoperitoneum platforms, and surgical instruments [3] - The company's core product, Sentire® laparoscopic surgical robot, has received approval from the National Medical Products Administration (NMPA) in China and is being used in top hospitals across mainland China, Hong Kong, and Europe [3] Technological Advancements - In August 2025, Cornerstone Robotics collaborated with a research team from the Chinese University of Hong Kong to develop the world's first multifunctional automated intelligent platform for surgical robots, successfully completing the first autonomous surgery in a clinical setting [3] - This achievement marks a significant step in the verification of autonomous technology in laparoscopic surgical robots in China, demonstrating capabilities in multi-task autonomous operation and human-machine collaboration [3] Future Directions - Cornerstone Robotics aims to transform its innovative technological achievements into a driving force for the development of a global smart healthcare ecosystem, focusing on clinical training, technical demonstration, and academic exchange [4] - The CEO, Professor Ou Guowei, emphasized the commitment to innovation and global expansion, aiming to provide high-quality and affordable surgical robot products to those in need worldwide [4]